Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selenium-induced thyroid dysfunction

L C Hofbauer1, C Spitzweg, R A Magerstädt

  • 1Division of Endocrinology, Klinikum Innenstadt, Ludwig-Maximilians-Universität, Germany.

Postgraduate Medical Journal
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of the standardization framework SSTR-RADS 1.0 for neuroendocrine tumors using the novel SSTR‑targeting peptide [<sup>18</sup>F]SiTATE.

European radiology·2024
Same author

[Imaging of neuroendocrine tumors of the gastrointestinal tract : Value of (hybrid) imaging diagnostics in radiology].

Radiologie (Heidelberg, Germany)·2024
Same author

Diagnostic accuracy of SSR-PET/CT compared to histopathology in the identification of liver metastases from well-differentiated neuroendocrine tumors.

Cancer imaging : the official publication of the International Cancer Imaging Society·2023
Same author

Tracing TET1 expression in prostate cancer: discovery of malignant cells with a distinct oncogenic signature.

Clinical epigenetics·2021
Same author

The sodium iodide symporter (NIS): novel applications for radionuclide imaging and treatment.

Endocrine-related cancer·2021
Same author

Is a treat-to-target strategy in osteoporosis applicable in clinical practice? Consensus among a panel of European experts.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same journal

Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

Postgraduate medical journal·2026
Same journal

Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

Postgraduate medical journal·2026
Same journal

Care, cash, and proof: forensic accountability for war-related starvation.

Postgraduate medical journal·2026
Same journal

Response to traumatic injuries in polo players in England.

Postgraduate medical journal·2026
Same journal

Aids to venesection and parenteral drug administration in patients with difficult veins.

Postgraduate medical journal·2026
Same journal

Diagnostic reasoning in clinical neurology: a comprehensive primer.

Postgraduate medical journal·2026
See all related articles

High-dose selenium supplementation, while investigated for inflammatory conditions, can cause severe hypothyroidism. This risk was observed in a sepsis patient, highlighting the need for careful monitoring and iodine supplementation.

Area of Science:

  • Trace element metabolism
  • Endocrinology
  • Critical care medicine

Background:

  • Selenium's antioxidant properties are being explored for inflammatory diseases.
  • Potential risks associated with high-dose selenium administration are not well-defined.

Observation:

  • A patient with sepsis secondary to pneumonia received high-dose intravenous selenite as adjunctive therapy.
  • The patient developed significant hypothyroidism during selenium treatment.

Findings:

  • Severe iodine deficiency was concurrently identified in the patient.
  • Thyroid function normalized following iodine supplementation, suggesting a complex interaction.

Implications:

  • High-dose selenium may pose a risk for thyroid dysfunction, particularly in iodine-deficient individuals.

Related Experiment Videos

  • Iodine supplementation may be crucial for mitigating selenium-induced hypothyroidism in susceptible patients.
  • Further research is needed to elucidate the precise mechanisms and clinical implications of selenium-iodine interactions in critical illness.